Skip to content
OpenCapital
Get started

Veradermics MANE Q4 2025 Annual earnings

Reported February 25, 2026

Diluted EPS-$1.63Beat by $0.19
EPS estimate-$1.81

Next report

Aug 11, 2026 (In 4 weeks)
EPS estimate-$0.66

Financials

Q4 2025

Balance sheet

See full
Cash & equivalents$21.8M-59.0%
Total debt$4.0K—
Total equity-$121.0M-150%
Total assets$152.6M+175%

Versus estimates

Diluted EPS

Q1 2026-$1.32Miss by $0.76Q4 2024-$1.06Beat by $0.75
Q4 2025-$1.63Beat by $0.19

Ask the moment Veradermics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Veradermics report Q4 2025 earnings?
Veradermics (MANE) reported Q4 2025 earnings on February 25, 2026.
What were Veradermics 's Q4 2025 revenue and EPS?
Veradermics reported diluted EPS of $-1.63 for Q4 2025.
Did Veradermics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-1.81 by $0.19.
How did Veradermics 's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 53.2% from $-1.06.
Where can I find Veradermics 's Q4 2025 SEC filings?
You can read the 10-K periodic report (0001827635-26-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.